Corporate Governance at Sartorius Stedim Biotech S.A.

Corporate governance aligned with the interests of stakeholders, lawful and responsible conduct, and constructive cooperation between the managerial bodies and within the company in a spirit of mutual trust constitute the essential cornerstones of Sartorius’ corporate culture.

Board of Directors and Committees

According to the definition of the aforementioned Article L 225-18-1 and L 22-10-03, the Board of Directors of Sartorius Stedim Biotech S.A. is composed of 43% of women as of December 31, 2024. If the Director representing the employees was taken into account, the Board of Directors would be composed of 50% of women.

 

icon-people

Board of Directors 

Learn More 

The Audit Committee assists the Board of Directors in areas relating to accounting policy, reporting, internal and external control, financial communication and management of the risks to which the company is exposed. 

Since July 18, 2024, the Audit Committee is in charge of all matters pertaining to sustainability, thereby becoming a combined committee (Financial Audit and ESG) in charge of preparing decisions for the Board of Directors to decide upon.

icon-people

Audit and Sustainability Committee 

Learn More 

The remuneration and Nomination Committee’s purpose is to assist the company’s Board of Directors in setting the remuneration policy for corporate officers and, in particular, relating to incentive mechanisms (allocation of stock options and bonus shares) that the company may implement.

icon-people

Remuneration and Nomination Committee

Learn More 

Remuneration 

The remuneration report describes the main features of the remuneration system of the Members of the Board and of the Executive Corporate Officers and provides individualised information on the remuneration due or awarded. 

The remuneration policy describes the remuneration policy for the Chief Executive Officer for the 2025 financial year, which was decided by the Board of Directors in its meeting held on February 5, 2025, upon proposal of the Remuneration and Nomination Committee, approved by the shareholders’ meeting  on March 25, 2025 (ex ante vote) with an affirmative vote of 92.04 % of the votes cast. 

Corporate Governance Documents 

Pursuant to Article L. 225 - 37 of the French Commercial Code, the Board of Directors uses this report, which covers each fiscal year ended December 31 of each year, to present the conditions of the preparation and organization of the work of the Board of Directors and the internal controlling and control procedures implemented by the company within the Group. 

Please click below to download the documents 

Compliance 
icon-e-mail
Investors Contact